Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3339 of 6351
-
Could a simple filter tame the deadly inflammation of heart shock?
Disease control CompletedThe Oxiris membrane is an AN-69 membrane whose surface is treated with polyethyleneimine (PEI) grafted with heparin. This property allows the removal of lipopolysaccharide and cytokines from the blood. During septic shock, this membrane has shown its effectiveness and made it pos…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug PEP-010 shows promise in early cancer trial
Disease control CompletedThis is an open-label, non-controlled, multicenter, dose escalation, first-in-human phase I clinical trial with an expansion phase designed to assess the safety, tolerability, PK and PD parameters, and preliminary antitumor activity of intravenous dosing of PEP-010 as single agen…
Early phase 1 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a common arthritis drug tame Sjogren's syndrome?
Disease control OngoingBackground: An autoimmune disease is one in which the immune system attacks a person's own body. Sjogren's syndrome (SS) is an autoimmune disease. It often involves multiple systems and organs of the body. Researchers are trying to find new, more effective and safe treatments fo…
Phase 1/2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could 'Good' bacteria beat a common vaginal infection?
Disease control CompletedThis is a mutilcenter, randomized, double-blind, Metronidazole controlled phase lIa clinical study to evaluate the safety and tolerability of dual - live lactobacilli-containing vaginal capsules for the treatment of Bacterial Vaginosis.
Phase 2 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New study shows tofacitinib helps control psoriatic arthritis in daily life
Disease control CompletedThis is a Multinational Study of Tofacitinib in Patients Treated for Psoriatic Arthritis in order to evaluate the effectiveness of treatment with tofacitinib on disease activity, remission, and Quality of Life, in a real-world setting over a 12-month observation period
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Heart bypass patients: does a stronger blood thinner keep grafts working longer?
Disease control Recruiting nowThe purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 m…
Sponsor: University Hospital, Linkoeping • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Sleep apnea drug shows promise for brain fog
Symptom relief CompletedThe purpose of study JZP110-405 is to determine whether solriamfetol is effective at improving cognitive function in participants with excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) plus impaired cognitive function.
Phase 4 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Could a Lab-Made antibody be the next acne breakthrough?
Disease control CompletedEfficacy and Safety of Imsidolimab in Participants with Acne Vulgaris
Phase 2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New pill combo aims to tame hepatitis d in small trial
Disease control CompletedOpen label, single arm, multi-center clinical trial of lonafarnib 50 mg QD plus ritonavir 200 mg QD, administered orally, over a 48-week treatment period, with a 24-week post-treatment follow-up period, in patients with chronic Hepatitis D Virusinfection. Objectives: To evaluate…
Phase 3 • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Shock to the system: electrical zaps may help stroke patients stay on their feet
Symptom relief Recruiting nowThe aim of this study is to describe the effect of neuromuscular electrical stimulation (NMES) in the form of functional electrical stimulation (FES) applied to different lower limb muscles on reactive balance and gait performance in stroke participants. Methods: Twenty individu…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Veterans helping veterans: peer support may lower suicide risk
Symptom relief CompletedVeterans Health Administration (VHA) suicide rates remain high, requiring new approaches. VHA patients tend to have high medical and behavioral health care needs that cause disruption in their lives and heighten their risk of suicide. This study will adapt and pilot test an inter…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Shocking therapy may keep cancer patients on their feet
Symptom relief CompletedSome blood, bone marrow, and lymphatic (hematologic) cancers such as Hodgkin/Non-Hodgkin lymphomas, chronic lymphocytic leukemia, and multiple myeloma, are over-represented in Veterans due to exposures including Agent Orange and an increased percentage of patients of African Amer…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Can a video chat program ease the burden of Alzheimer's caregiving?
Symptom relief CompletedThe purpose of this study is to test a revised psychoeducational intervention to help Care Partners for family members with dementia understand and reduce the distressing behaviors that come with progressive dementia. Tele-STELLA (Support via TEchnology: Living and Learning with …
Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New online program aims to ease pain for cancer survivors
Symptom relief OngoingTo determine whether an Internet-based pain coping skills program plus enhanced usual care, compared to enhanced usual care alone, yields significant improvements in the co-primary outcomes of pain severity (as measured by the Brief Pain Inventory (BPI)) and pain interference (al…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Experimental triple combo for tough breast cancer shows early promise but trial stops short
Disease control Stopped earlyThe purpose of this research study is to test the safety and effectiveness of docetaxel chemotherapy and pembrolizumab plus adenoviral-mediated interleukin-12 (ADV/IL-12) gene therapy in patients with anthracycline-refractory, triple negative breast cancer (TNBC).
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New pill shows promise for diabetes control in Real-World study
Disease control CompletedThe purpose of the study is to collect information on how Rybelsus® works in people with type 2 diabetes and to see if Rybelsus® can lower their blood sugar levels. Participants will get Rybelsus® as prescribed by the study doctor. The study will last for about 8-10 months. Parti…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New program aims to boost living kidney donations
Knowledge-focused OngoingFor patients with kidney failure the two treatment options are kidney transplantation or dialysis. Transplantation offers longer survival, better quality of life and provides cost savings for the health system (\>$60,000/year per patient). Unfortunately, there are not enough orga…
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Real-World study tracks Osimertinib's impact on lung cancer survival
Knowledge-focused OngoingThis is an observational multicenter study. A cross-sectional descriptive study of patients with locally advanced or metastatic Non Small Cell Lung Cancer with activating EGFR mutation treated by any first line therapy will be used to identify cohort with a prospective follow-up …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Protein clue could unlock new autoimmune treatments
Knowledge-focused Recruiting nowThe aim of this study is to determine the expression of STIM1 in the plasma membrane of lymphocytes from patients suffering from different autoimmune diseases in order to identify new pathologies of interest presenting an over-expression of STIM1PM. This would allow to initiate,…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Scientists hunt for genes that spark brain inflammation in Alzheimer's
Knowledge-focused OngoingThe primary objectives are to validate that a previously identified gene variant influences the proportion of activated microglia (PAM) and the amount of TSPO binding on PET imaging, to identify novel loci that influence PAM and TSPO PET, and to understand the functional conseque…
Phase 2 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC